Pathalys Pharma, the Research Triangle Park-based biopharmaceutical company developing therapies for end-stage kidney disease, has secured $150 million in new…
Startups and emerging companies in North Carolina have more access to venture capital with the expansion of international firm SixThirty Ventures opening…
The North Carolina Biotechnology Center awarded 32 grants and loans totaling $3,304,543 to universities, bioscience companies and nonprofit organizations in…